Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
MCRB

Seres Therapeutics

$9.41

-0.51 (-5.14%)

07:55
01/31/17
01/31
07:55
01/31/17
07:55
Conference/Events
Seres Therapeutics to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 09

    Mar

MCRB

Seres Therapeutics

$9.41

-0.51 (-5.14%)

07:06
01/31/17
01/31
07:06
01/31/17
07:06
Hot Stocks
Seres says discussions ongoing with FDA regarding redesigned SER-109 study »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 09

    Mar

MCRB

Seres Therapeutics

$9.41

-0.51 (-5.14%)

04:55
01/31/17
01/31
04:55
01/31/17
04:55
Conference/Events
Seres Therapeutics to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 09

    Mar

MCRB

Seres Therapeutics

$9.41

-0.51 (-5.14%)

16:09
01/30/17
01/30
16:09
01/30/17
16:09
Conference/Events
Seres Therapeutics to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Mar

Over a month ago
MCRB

Seres Therapeutics

$10.95

-0.05 (-0.45%)

09:16
01/11/17
01/11
09:16
01/11/17
09:16
Recommendations
Seres Therapeutics analyst commentary at Cantor »

Seres still has major…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCRB

Seres Therapeutics

$9.20

0.21 (2.34%)

05:48
12/16/16
12/16
05:48
12/16/16
05:48
Initiation
Seres Therapeutics initiated at Cantor »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
MCRB

Seres Therapeutics

$11.40

0.81 (7.65%)

07:33
11/10/16
11/10
07:33
11/10/16
07:33
Earnings
Seres Therapeutics reports Q3 EPS (46c), consensus (50c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCRB

Seres Therapeutics

$9.73

0.52 (5.65%)

09:19
08/12/16
08/12
09:19
08/12/16
09:19
Recommendations
Seres Therapeutics analyst commentary at FBR Capital »

Seres Therapeutics recent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCRB

Seres Therapeutics

$9.21

-0.32 (-3.36%)

07:03
08/11/16
08/11
07:03
08/11/16
07:03
Hot Stocks
Seres Therapeutics sees cash position supporting operations 'well into' 2018 »

Seres ended the second…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Aug

MCRB

Seres Therapeutics

$9.21

-0.32 (-3.36%)

07:02
08/11/16
08/11
07:02
08/11/16
07:02
Earnings
Seres Therapeutics reports Q2 EPS (70c), consensus (46c) »

Reports Q2 revenue $3.0M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.